Envoy Medical (COCH) Competitors $1.42 +0.02 (+1.43%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COCH vs. LUCD, OBIO, AVR, INFU, KRMD, SKIN, MGRM, ICAD, NSPR, and MBOTShould you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), Anteris Technologies Global (AVR), InfuSystem (INFU), KORU Medical Systems (KRMD), Beauty Health (SKIN), Monogram Orthopaedics (MGRM), iCAD (ICAD), InspireMD (NSPR), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry. Envoy Medical vs. Lucid Diagnostics Orchestra BioMed Anteris Technologies Global InfuSystem KORU Medical Systems Beauty Health Monogram Orthopaedics iCAD InspireMD Microbot Medical Envoy Medical (NASDAQ:COCH) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, valuation, profitability and risk. Does the media prefer COCH or LUCD? In the previous week, Envoy Medical had 6 more articles in the media than Lucid Diagnostics. MarketBeat recorded 12 mentions for Envoy Medical and 6 mentions for Lucid Diagnostics. Envoy Medical's average media sentiment score of 0.88 beat Lucid Diagnostics' score of 0.73 indicating that Envoy Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lucid Diagnostics 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Which has more volatility & risk, COCH or LUCD? Envoy Medical has a beta of 2.35, indicating that its share price is 135% more volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Does the MarketBeat Community favor COCH or LUCD? Lucid Diagnostics received 32 more outperform votes than Envoy Medical when rated by MarketBeat users. However, 100.00% of users gave Envoy Medical an outperform vote while only 68.97% of users gave Lucid Diagnostics an outperform vote. CompanyUnderperformOutperformEnvoy MedicalOutperform Votes8100.00% Underperform VotesNo VotesLucid DiagnosticsOutperform Votes4068.97% Underperform Votes1831.03% Is COCH or LUCD more profitable? Lucid Diagnostics has a net margin of -1,069.87% compared to Envoy Medical's net margin of -7,607.55%. Company Net Margins Return on Equity Return on Assets Envoy Medical-7,607.55% N/A -262.28% Lucid Diagnostics -1,069.87%N/A -123.54% Which has preferable earnings & valuation, COCH or LUCD? Envoy Medical has higher earnings, but lower revenue than Lucid Diagnostics. Lucid Diagnostics is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$225K134.60-$29.91M-$1.41-1.01Lucid Diagnostics$4.35M30.31-$52.67M-$1.08-1.16 Do institutionals and insiders hold more shares of COCH or LUCD? 8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are owned by institutional investors. 60.5% of Envoy Medical shares are owned by company insiders. Comparatively, 8.8% of Lucid Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts rate COCH or LUCD? Envoy Medical currently has a consensus target price of $9.13, indicating a potential upside of 542.61%. Lucid Diagnostics has a consensus target price of $3.50, indicating a potential upside of 180.00%. Given Envoy Medical's higher possible upside, equities analysts plainly believe Envoy Medical is more favorable than Lucid Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 SummaryEnvoy Medical and Lucid Diagnostics tied by winning 9 of the 18 factors compared between the two stocks. Get Envoy Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCH vs. The Competition Export to ExcelMetricEnvoy MedicalSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.28M$9.15B$5.57B$7.82BDividend YieldN/A1.64%5.11%4.22%P/E Ratio-1.0119.2522.4418.48Price / Sales134.6072.03394.66103.91Price / CashN/A19.6738.1834.62Price / Book-15.784.956.774.25Net Income-$29.91M$284.66M$3.22B$248.23M7 Day Performance-2.07%3.01%3.09%3.29%1 Month Performance4.41%-0.15%-0.14%2.43%1 Year Performance-66.59%-14.81%17.98%5.54% Envoy Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCHEnvoy Medical2.3634 of 5 stars$1.42+1.4%$9.13+542.6%-71.5%$30.28M$225,000.00-1.0134LUCDLucid Diagnostics2.4989 of 5 stars$1.20-0.8%$3.50+191.7%+67.8%$108.91M$4.35M-1.0570OBIOOrchestra BioMed2.7398 of 5 stars$2.84-0.4%$15.00+428.2%-42.4%$108.81M$2.64M-1.764News CoverageGap UpAVRAnteris Technologies GlobalN/A$3.14+9.0%$16.50+425.5%N/A$103.57M$2.71M0.00138News CoveragePositive NewsINFUInfuSystem1.4951 of 5 stars$4.91flat$13.00+164.8%N/A$103.19M$134.86M81.85410Positive NewsKRMDKORU Medical Systems3.2481 of 5 stars$2.24-1.3%$4.70+109.8%+17.5%$102.94M$33.65M-8.9680Upcoming EarningsNews CoverageSKINBeauty Health1.9911 of 5 stars$0.82-2.9%$2.50+204.4%-69.0%$102.86M$334.29M-1.961,030MGRMMonogram Orthopaedics2.4522 of 5 stars$2.65-1.9%$5.40+103.8%+28.0%$93.52M$364,999.00-5.6428News CoverageICADiCAD0.59 of 5 stars$3.03-5.9%N/A+131.1%$82.92M$19.61M-23.31140News CoverageGap DownHigh Trading VolumeNSPRInspireMD2.5397 of 5 stars$2.60+0.4%$4.75+82.7%+26.9%$79.65M$7.01M-3.4750Analyst ForecastNews CoverageMBOTMicrobot Medical1.863 of 5 stars$2.23-10.4%$9.00+303.6%+176.1%$77.48MN/A-2.7920Positive News Related Companies and Tools Related Companies Lucid Diagnostics Competitors Orchestra BioMed Competitors Anteris Technologies Global Competitors InfuSystem Competitors KORU Medical Systems Competitors Beauty Health Competitors Monogram Orthopaedics Competitors iCAD Competitors InspireMD Competitors Microbot Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COCH) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COCH Stock Free COCH Stock Alerts